Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Specimen Collection for Development and Performance Evaluation of the LumiraDx Platform Point of Care Tests for Sars-Cov-2 IgG/IgM & Antigen to be Used as an Aid in Diagnosis of COVID-19

NCT04408066 is registered in ClinicalTrials.gov with LumiraDx UK Limited as lead sponsor.

NCT NCT04408066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04408066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Specimen Collection for Development and Performance Evaluation of the LumiraDx Platform Point of Care Tests for Sars-Cov-2 IgG/IgM & Antigen to be Used as an Aid in Diagnosis of COVID-19
Lead sponsor
LumiraDx UK Limited
Phase
Observational
Overall status
Completed
Start date
May 1, 2020
Completion date
May 26, 2020
Enrollment
523 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19